DNA Mismatch Repair Status in FOLFOX-Treated Stage III Colon Cancer
This pooled analysis of 2 randomized clinical trials evaluates the association of DNA mismatch repair status with disease-free survival in patients with stage III colon cancer treated with FOLFOX.
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου